Need Help?

IBMsnRNAseq

snRNA-seq and spatial transcriptomic data and analysis of healthy (CTRL) and inflamed (immune-mediated necrotizing myopathy (IMNM) and inclusion body myositis (IBM)) human quadriceps muscle. This data set includes 19 snRNA-seq (7 CTRL, 4 IMNM, 8 IBM) and 8 ST samples (3 CTRL, 2 IMNM, 3 IBM).

Request Access

DAC IBMsnRNAseq Data Access Policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorized Personnel: The individuals at the User Institution to whom the DAC IBMsnRNAseq grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorized Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: The DAC IBMsnRNAseq and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. DAC IBMsnRNAseq: Data Access Committee, Laboratory of Lucas Schirmer, Medical Faculty Mannheim, Heidelberg University, Germany 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorized Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognizing the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the DAC IBMsnRNAseq within 30 days of any changes or departures of Authorized Personnel. 13. The User Institution will notify the DAC IBMsnRNAseq prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the DAC IBMsnRNAseq as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. The DAC IBMsnRNAseq may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than the DAC IBMsnRNAseq. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorized Personnel. The User Institution will procure that the Authorized Personnel comply with the terms of this agreement.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000310 RNASeq

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF50000101324 fastq.gz 2.1 GB
EGAF50000101325 fastq.gz 16.2 GB
EGAF50000101326 fastq.gz 18.7 GB
EGAF50000101327 fastq.gz 1.9 GB
EGAF50000101328 fastq.gz 14.6 GB
EGAF50000101329 fastq.gz 16.2 GB
EGAF50000101330 fastq.gz 2.1 GB
EGAF50000101331 fastq.gz 16.3 GB
EGAF50000101332 fastq.gz 18.3 GB
EGAF50000101333 fastq.gz 1.6 GB
EGAF50000101334 fastq.gz 11.7 GB
EGAF50000101335 fastq.gz 14.7 GB
EGAF50000101336 fastq.gz 2.2 GB
EGAF50000101337 fastq.gz 17.6 GB
EGAF50000101338 fastq.gz 20.3 GB
EGAF50000101339 fastq.gz 1.4 GB
EGAF50000101340 fastq.gz 10.7 GB
EGAF50000101341 fastq.gz 12.8 GB
EGAF50000101342 fastq.gz 2.0 GB
EGAF50000101343 fastq.gz 15.0 GB
EGAF50000101344 fastq.gz 16.7 GB
EGAF50000101345 fastq.gz 2.2 GB
EGAF50000101346 fastq.gz 16.2 GB
EGAF50000101347 fastq.gz 18.5 GB
EGAF50000101348 fastq.gz 2.1 GB
EGAF50000101349 fastq.gz 16.2 GB
EGAF50000101350 fastq.gz 18.2 GB
EGAF50000101351 fastq.gz 32.5 GB
EGAF50000101352 fastq.gz 41.5 GB
EGAF50000101353 fastq.gz 3.1 GB
EGAF50000101354 fastq.gz 3.3 GB
EGAF50000101355 fastq.gz 1.7 GB
EGAF50000101356 fastq.gz 7.4 GB
EGAF50000101357 fastq.gz 15.3 GB
EGAF50000101358 fastq.gz 20.1 GB
EGAF50000101359 fastq.gz 2.1 GB
EGAF50000101360 fastq.gz 1.6 GB
EGAF50000101361 fastq.gz 12.1 GB
EGAF50000101362 fastq.gz 14.8 GB
EGAF50000101363 fastq.gz 21.5 GB
EGAF50000101364 fastq.gz 1.6 GB
EGAF50000101365 fastq.gz 1.8 GB
EGAF50000101366 fastq.gz 20.4 GB
EGAF50000101367 fastq.gz 2.0 GB
EGAF50000101368 fastq.gz 15.3 GB
EGAF50000101369 fastq.gz 17.1 GB
EGAF50000101370 fastq.gz 1.8 GB
EGAF50000101371 fastq.gz 12.9 GB
EGAF50000101372 fastq.gz 15.1 GB
EGAF50000101373 fastq.gz 36.4 GB
EGAF50000101374 fastq.gz 29.7 GB
EGAF50000101375 fastq.gz 2.6 GB
EGAF50000101376 fastq.gz 2.2 GB
EGAF50000101377 fastq.gz 17.2 GB
EGAF50000101378 fastq.gz 20.6 GB
EGAF50000101379 fastq.gz 7.1 GB
EGAF50000101380 fastq.gz 934.9 MB
EGAF50000101381 fastq.gz 8.7 GB
EGAF50000101382 fastq.gz 11.9 GB
EGAF50000101383 fastq.gz 14.3 GB
EGAF50000101384 fastq.gz 1.6 GB
EGAF50000101385 fastq.gz 2.5 GB
EGAF50000101386 fastq.gz 2.5 GB
EGAF50000101387 fastq.gz 25.7 GB
EGAF50000101388 fastq.gz 21.2 GB
EGAF50000101389 fastq.gz 30.7 GB
EGAF50000101390 fastq.gz 2.5 GB
EGAF50000101391 fastq.gz 31.9 GB
EGAF50000101392 fastq.gz 2.5 GB
EGAF50000101393 fastq.gz 27.9 GB
EGAF50000101394 fastq.gz 27.1 GB
EGAF50000101395 fastq.gz 2.4 GB
EGAF50000101396 fastq.gz 2.0 GB
EGAF50000101397 fastq.gz 3.2 GB
EGAF50000101398 fastq.gz 2.6 GB
EGAF50000101399 fastq.gz 2.6 GB
EGAF50000101400 fastq.gz 8.4 GB
EGAF50000101401 fastq.gz 19.4 GB
EGAF50000101402 fastq.gz 2.4 GB
EGAF50000101403 fastq.gz 2.4 GB
EGAF50000101404 fastq.gz 23.9 GB
EGAF50000101405 fastq.gz 28.4 GB
EGAF50000101406 fastq.gz 2.8 GB
EGAF50000101407 fastq.gz 2.4 GB
EGAF50000101408 fastq.gz 26.9 GB
EGAF50000101409 fastq.gz 2.9 GB
EGAF50000101410 fastq.gz 30.1 GB
EGAF50000101411 fastq.gz 2.6 GB
EGAF50000101412 fastq.gz 29.3 GB
EGAF50000101413 h5ad 175 Bytes
EGAF50000101414 tif 139.3 MB
EGAF50000101415 tif 124.9 MB
EGAF50000101416 tif 139.0 MB
EGAF50000101417 tif 130.6 MB
EGAF50000101418 tif 155.6 MB
EGAF50000101419 tif 139.0 MB
EGAF50000101420 tif 138.7 MB
EGAF50000101421 h5ad 224.8 MB
EGAF50000101422 tif 142.7 MB
EGAF50000101423 h5ad 314.5 MB
EGAF50000101424 h5ad 668.2 MB
EGAF50000101425 h5ad 359.0 MB
102 Files (1.1 TB)